Definium Therapeutics Scores Another Win For Its LSD-Based Drug; Shares Pop
Key Points:
- Investor’s Business Daily provides information for educational purposes only and does not offer investment advice or recommendations to buy or sell securities.
- The information is sourced from what are believed to be reliable sources, but accuracy, timeliness, and suitability are not guaranteed.
- Past investment performance mentioned is not indicative of future results, and authors may hold positions in the stocks they discuss.
- Real-time prices are provided by Nasdaq Last Sale but do not cover all markets; ownership and estimate data come from LSEG and FactSet respectively.
- All trademarks and content are owned by Investor’s Business Daily, LLC, with terms of use governing the service, and information is subject to change without notice.